USD 63.48
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -5.76 USD | -350.0% |
2023 | -1.28 USD | -146.72% |
2022 | 2.74 USD | -13.02% |
2021 | 3.15 USD | 173.91% |
2020 | 1.15 USD | 21.05% |
2019 | 0.95 USD | 48.44% |
2018 | 0.64 USD | -27.27% |
2017 | 0.88 USD | -1.12% |
2016 | 0.89 USD | -49.72% |
2015 | 1.77 USD | 1164.29% |
2014 | 0.14 USD | 135.0% |
2013 | -0.40 USD | -90.48% |
2012 | -0.21 USD | 54.35% |
2011 | -0.46 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -1.13 USD | 71.39% |
2024 FY | - USD | -350.0% |
2024 Q3 | -0.55 USD | 51.33% |
2024 Q4 | 0.13 USD | 123.64% |
2024 Q1 | -3.95 USD | -722.92% |
2023 Q4 | -0.48 USD | 61.6% |
2023 Q3 | -1.25 USD | -377.78% |
2023 Q2 | 0.45 USD | 0.0% |
2023 FY | - USD | -146.72% |
2023 Q1 | - USD | -100.0% |
2022 Q3 | 0.78 USD | 47.17% |
2022 FY | - USD | -13.02% |
2022 Q1 | 0.49 USD | -50.0% |
2022 Q4 | 1.04 USD | 33.33% |
2022 Q2 | 0.53 USD | 8.16% |
2021 Q4 | 0.98 USD | -22.83% |
2021 FY | - USD | 173.91% |
2021 Q3 | 1.27 USD | 176.09% |
2021 Q1 | 0.42 USD | -51.16% |
2021 Q2 | 0.46 USD | 9.52% |
2020 FY | - USD | 21.05% |
2020 Q3 | 0.14 USD | -39.13% |
2020 Q2 | 0.23 USD | 32757.14% |
2020 Q4 | 0.86 USD | 514.29% |
2020 Q1 | 0.00 USD | -99.84% |
2019 FY | - USD | 48.44% |
2019 Q1 | -0.10 USD | -116.13% |
2019 Q2 | 0.34 USD | 440.0% |
2019 Q3 | 0.22 USD | -35.29% |
2019 Q4 | 0.45 USD | 104.55% |
2018 Q1 | 0.03 USD | -93.88% |
2018 Q4 | 0.62 USD | 342.86% |
2018 Q3 | 0.14 USD | 187.5% |
2018 Q2 | -0.16 USD | -633.33% |
2018 FY | - USD | -27.27% |
2017 Q2 | 0.14 USD | 250.0% |
2017 Q3 | 0.21 USD | 50.0% |
2017 Q4 | 0.49 USD | 133.33% |
2017 FY | - USD | -1.12% |
2017 Q1 | 0.04 USD | -91.49% |
2016 FY | - USD | -49.72% |
2016 Q2 | 0.25 USD | 242.94% |
2016 Q4 | 0.47 USD | 422.22% |
2016 Q1 | 0.07 USD | -94.07% |
2016 Q3 | 0.09 USD | -64.0% |
2015 FY | - USD | 1164.29% |
2015 Q4 | 1.23 USD | 392.0% |
2015 Q1 | -0.19 USD | -182.61% |
2015 Q3 | 0.25 USD | -32.43% |
2015 Q2 | 0.37 USD | 294.74% |
2014 Q2 | -0.16 USD | -1350.0% |
2014 FY | - USD | 135.0% |
2014 Q3 | 0.06 USD | 135.69% |
2014 Q1 | 0.01 USD | -92.0% |
2014 Q4 | 0.23 USD | 302.8% |
2013 Q3 | -0.16 USD | 30.43% |
2013 Q4 | 0.16 USD | 200.0% |
2013 FY | - USD | -90.48% |
2013 Q1 | -0.17 USD | 0.0% |
2013 Q2 | -0.23 USD | -35.29% |
2012 FY | - USD | 54.35% |
2011 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Amneal Pharmaceuticals, Inc. | -0.48 USD | -1100.0% |
Bausch Health Companies Inc. | -1.62 USD | -255.556% |
Emergent BioSolutions Inc. | -14.85 USD | 61.212% |
Elanco Animal Health Incorporated | -2.50 USD | -130.4% |
Perrigo Company plc | -0.09 USD | -6034.185% |
Teva Pharmaceutical Industries Limited | -0.50 USD | -1052.0% |
Zoetis Inc. | 5.08 USD | 213.386% |